Cargando…

Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines

Monotherapy for triple−negative breast cancer (TNBC) is often ineffective. This study aimed to investigate the effect of calcitriol and talazoparib combination on cell proliferation, migration, apoptosis and cell cycle in TNBC cell lines. Monotherapies and their combination were studied for (i.) ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Fu Hou, Palanirajan, Vijayaraj Kumar, Ng, Edmond Siah Chye, Tan, Chung Keat, Tan, Eugenie Sin Sing, Amini, Farahnaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504984/ https://www.ncbi.nlm.nih.gov/pubmed/36145297 http://dx.doi.org/10.3390/ph15091075

Ejemplares similares

Effect of Rice (Oryza sativa L.) Ceramides Supplementation on Improving Skin Barrier Functions and Depigmentation: An Open-Label Prospective Study
por: Leo, Teik Kee, et al.
Publicado: (2022)

Effect of tiger milk mushroom (Lignosus rhinocerus) supplementation on respiratory health, immunity and antioxidant status: an open-label prospective study
por: Tan, Eugenie Sin Sing, et al.
Publicado: (2021)

Effects of Ambient Particulate Matter (PM(2.5)) Exposure on Calorie Intake and Appetite of Outdoor Workers
por: Sundram, Thavin Kumar Mathana, et al.
Publicado: (2022)

Mental Health and the COVID-19 Pandemic: Observational Evidence from Malaysia
por: Tan, Eugenie Sin Sing, et al.
Publicado: (2023)

Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update
por: Segovia-Mendoza, Mariana, et al.
Publicado: (2021)

Enhanced gastrointestinal survivability of recombinant Lactococcus lactis using a double coated mucoadhesive film approach
por: Tan, Ee Wern, et al.
Publicado: (2019)

Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts
por: García-Quiroz, Janice, et al.
Publicado: (2019)

Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2022)

Evidence to date: talazoparib in the treatment of breast cancer
por: Exman, Pedro, et al.
Publicado: (2019)

Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates
por: Pyreddy, Suneela, et al.
Publicado: (2014)

MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer
por: Wang, Tao, et al.
Publicado: (2022)

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study
por: Litton, Jennifer K, et al.
Publicado: (2023)

Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel
por: Pandurangan, Dinesh Kumar, et al.
Publicado: (2016)

Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin
por: Albasri, Omar Waleed Abduljaleel, et al.
Publicado: (2023)

Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
por: Blum, Joanne L., et al.
Publicado: (2022)

Cyclodextrin inclusion complex inhibits circulating galectin-3 and FGF-7 and affects the reproductive integrity and mobility of Caco-2 cells
por: Maki, Marwan Abdelmahmoud Abdelkarim, et al.
Publicado: (2020)

Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
por: Boussios, Stergios, et al.
Publicado: (2020)

Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib
por: Li, Jiaguo, et al.
Publicado: (2020)

A Phase I trial of talazoparib in patients with advanced hematologic malignancies
por: Gopal, Ajay K, et al.
Publicado: (2021)

Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer
por: Klein, Florian G., et al.
Publicado: (2021)

Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
por: Zhou, Dong, et al.
Publicado: (2021)

PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
por: Jonuscheit, Stephanie, et al.
Publicado: (2021)

Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
por: Lee, Yueh-Ting, et al.
Publicado: (2013)

“Calcitriol” Is Not Synonymous with “Vitamin D”
por: Kimball, Samantha M., et al.
Publicado: (2012)

Calcitriol Inhibits the Proliferation of Triple-Negative Breast Cancer Cells through a Mechanism Involving the Proinflammatory Cytokines IL-1β and TNF-α
por: Martínez-Reza, Isela, et al.
Publicado: (2019)

PEGylated talazoparib enhances therapeutic window of its combination with temozolomide in Ewing sarcoma
por: Del Pozo, Vanessa, et al.
Publicado: (2021)

The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors
por: Durairaj, Chandrasekar, et al.
Publicado: (2021)

Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany
por: Schwarz, Florian, et al.
Publicado: (2022)

Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer
por: Yang, Shicheng, et al.
Publicado: (2023)

A Review: The Antiviral Activity of Cyclic Peptides
por: Chia, Le Yi, et al.
Publicado: (2022)

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer
por: Savill, Kristin M Zimmerman, et al.
Publicado: (2023)

Immunomodulatory Mechanisms of Action of Calcitriol in Psoriasis
por: Raychaudhuri, Suravi, et al.
Publicado: (2014)

Mechanistic Effects of Calcitriol in Cancer Biology
por: Díaz, Lorenza, et al.
Publicado: (2015)

The outcomes of dexmedetomidine and calcitriol on flap viability
por: Kotanoğlu, Mustafa Sırrı, et al.
Publicado: (2020)

Calcitriol and Levothyroxine Dosing for Patients With Pseudohypoparathyroidism
por: Antoun, Jacqueline, et al.
Publicado: (2021)

Rapid Nontranscriptional Effects of Calcifediol and Calcitriol
por: Donati, Simone, et al.
Publicado: (2022)

Pembrolizumab Induced Calcitriol-Mediated Hypercalcemia
por: Oommen, Tiffany T., et al.
Publicado: (2023)

Sustained Release Talazoparib Implants for Localized Treatment of BRCA1-deficient Breast Cancer
por: Belz, Jodi E., et al.
Publicado: (2017)

Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors
por: Hoffman, Justin, et al.
Publicado: (2019)

Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma
por: Baldwin, Paige, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lcpaiiq547pfp7m800g2fik1u7